Sackner M A, Epstein S, Wanner A
Chest. 1976 May;69(5):593-8. doi: 10.1378/chest.69.5.593.
The present study was designed to assess the effects of two beta-adrenergic agonists, isoproterenol sulfate and carbuterol hydrochloride, and aerosolized Freon propellant (a mixture of Freon II, Freon 12, and Freon 114) on tracheal mucous velocity and cardiac output in anesthetized dogs. Five groups of ten animals each received the following dosages of aerosols: Freon, 20 puffs; isoproterenol, four puffs; carbuterol, four puffs; isoproterenol, 20 puffs; and carbuterol, 20 puffs. The puff was delivered by a standard metered aerosol; each puff of isoproterenol spray contained 75 mug of isoproterenol sulfate, and each puff of carbuterol spray contained 100 mug of carbuterol hydrochloride. Tracheal mucous velocity was not changed by receiving Freon, but administration of both isoproterenol and carbuterol caused a significant increase in this measurement, with peak increases ranging from 74 to 111 percent above control values. The duration of action for four and 20 puffs of isoproterenol and for four puffs of carbuterol was two hours. Twenty puffs of carbuterol increased tracheal mucous velocity for three hours. Administration of carbuterol effected a slightly larger increase in cardiac output than isoproterenol. The duration of action for the increased cardiac output was shorter than the duration of action for the increased tracheal mucous velocity. These studies indicate that beta-adrenergic agonists may have an important role in improving mucous transport in patients with chronic obstructive pulmonary disease in whom mucociliary clearance is depressed.
本研究旨在评估两种β-肾上腺素能激动剂硫酸异丙肾上腺素和盐酸卡布特罗,以及雾化氟利昂推进剂(氟利昂II、氟利昂12和氟利昂114的混合物)对麻醉犬气管黏液速度和心输出量的影响。五组,每组十只动物,分别接受以下剂量的气雾剂:氟利昂,20喷;异丙肾上腺素,4喷;卡布特罗,4喷;异丙肾上腺素,20喷;以及卡布特罗,20喷。气雾剂由标准定量气雾剂递送;每喷异丙肾上腺素喷雾剂含有75μg硫酸异丙肾上腺素,每喷卡布特罗喷雾剂含有100μg盐酸卡布特罗。接受氟利昂后气管黏液速度未改变,但给予异丙肾上腺素和卡布特罗均导致该测量值显著增加,峰值增加范围比对照值高74%至111%。4喷和20喷异丙肾上腺素以及4喷卡布特罗的作用持续时间为2小时。20喷卡布特罗使气管黏液速度增加持续3小时。给予卡布特罗比异丙肾上腺素使心输出量增加略大。心输出量增加的作用持续时间比气管黏液速度增加的作用持续时间短。这些研究表明,β-肾上腺素能激动剂在改善慢性阻塞性肺疾病患者黏液转运方面可能具有重要作用,这些患者的黏液纤毛清除功能受到抑制。